Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
EMAMILTD.NS Stock Summary
Top 10 Correlated ETFs
EMAMILTD.NS
In the News
EMAMILTD.NS Financial details
Company Rating
Neutral
Market Cap
198.28B
Income
7.19B
Revenue
35.23B
Book val./share
-
Cash/share
-
Dividend
8
Dividend %
1.46%
Employees
3.24K
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
34.23
Forward P/E
-
PEG
-26.27
P/S
6.81
P/B
9.93
P/C
-
P/FCF
-
Quick Ratio
1.19
Current Ratio
1.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
16.42
EPS next Y
-
EPS next Q
-
EPS this Y
-23.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
16.77%
Revenue last 5Y
4.81%
Revenue Q/Q
15.2%
EPS Q/Q
44.74%
-
-
-
-
SMA20
2.04%
SMA50
-9.82%
SMA100
-10%
Inst Own
-
Inst Trans
-
ROA
21%
ROE
59%
ROC
0.3%
Gross Margin
66%
Oper. Margin
21%
Profit Margin
20%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
357.65-588.6
52W High
-25.3%
52W Low
+23.04%
RSI
45
Rel Volume
0.4
Avg Volume
742.66K
Volume
298.81K
Perf Week
-1.65%
Perf Month
-3.46%
Perf Quarter
-13.95%
Perf Half Y
-12.09%
-
-
-
-
Beta
0.773
-
-
Volatility
6.66%, 11.25%
Prev Close
-0.94%
Price
439.25
Change
-3.41%
EMAMILTD.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 59.32 | 58.49 | 64.81 | 71.06 | 77.21 | |
Net income per share | 6.68 | 6.67 | 10.23 | 18.88 | 14.5 | |
Operating cash flow per share | 12.2 | 11.69 | 20.73 | 14.49 | 16.98 | |
Free cash flow per share | 9.13 | 8.19 | 19.97 | 3.61 | 16.06 | |
Cash per share | 2.74 | 1.74 | 10.04 | 4.12 | 8.38 | |
Book value per share | 45.73 | 40.18 | 39.66 | 46.73 | 52.21 | |
Tangible book value per share | 26.4 | 26.49 | 31.67 | 33.5 | 40.1 | |
Share holders equity per share | 45.73 | 40.18 | 39.66 | 46.73 | 52.21 | |
Interest debt per share | 3.43 | 5.42 | 2.57 | 6.45 | 2.22 | |
Market cap | 183.48B | 77.15B | 216.02B | 198.7B | 158.15B | |
Enterprise value | 183.41B | 79.29B | 216.82B | 201.24B | 158.59B | |
P/E ratio | 60.51 | 25.47 | 47.51 | 23.68 | 24.73 | |
Price to sales ratio | 6.81 | 2.91 | 7.5 | 6.29 | 4.64 | |
POCF ratio | 33.14 | 14.54 | 23.44 | 30.86 | 21.12 | |
PFCF ratio | 44.26 | 20.76 | 24.33 | 123.96 | 22.32 | |
P/B Ratio | 8.84 | 4.23 | 12.26 | 9.57 | 6.87 | |
PTB ratio | 8.84 | 4.23 | 12.26 | 9.57 | 6.87 | |
EV to sales | 6.81 | 2.99 | 7.53 | 6.37 | 4.66 | |
Enterprise value over EBITDA | 24.48 | 10.92 | 23.8 | 20.66 | 17.16 | |
EV to operating cash flow | 33.12 | 14.94 | 23.53 | 31.26 | 21.18 | |
EV to free cash flow | 44.25 | 21.33 | 24.42 | 125.55 | 22.39 | |
Earnings yield | 0.02 | 0.04 | 0.02 | 0.04 | 0.04 | |
Free cash flow yield | 0.02 | 0.05 | 0.04 | 0.01 | 0.04 | |
Debt to equity | 0.06 | 0.12 | 0.06 | 0.14 | 0.04 | |
Debt to assets | 0.05 | 0.08 | 0.04 | 0.09 | 0.03 | |
Net debt to EBITDA | -0.01 | 0.29 | 0.09 | 0.26 | 0.05 | |
Current ratio | 1.25 | 1.3 | 1.61 | 1.17 | 1.78 | |
Interest coverage | 19.08 | 17.39 | 39.46 | 122.81 | 86.43 | |
Income quality | 1.37 | 1.42 | 1.62 | 0.94 | 1.12 | |
Dividend Yield | 0.01 | 0.05 | 0.02 | 0.02 | 0.02 | |
Payout ratio | 0.52 | 1.2 | 0.78 | 0.42 | 0.55 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.31 | 0.23 | 0.14 | 0.19 | 0.17 | |
Capex to operating cash flow | -0.25 | -0.3 | -0.04 | -0.75 | -0.05 | |
Capex to revenue | -0.05 | -0.06 | -0.01 | -0.15 | -0.01 | |
Capex to depreciation | -0.43 | -0.47 | -0.09 | -1.44 | -0.16 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 82.91 | 77.67 | 95.54 | 140.89 | 130.51 | |
ROIC | 0.14 | 0.14 | 0.22 | 0.32 | 0.25 | |
Return on tangible assets | 0.16 | 0.15 | 0.21 | 0.34 | 0.25 | |
Graham Net | -4.12 | -5.14 | 0.99 | -8.18 | 1.19 | |
Working capital | 1.69B | 2.41B | 4.27B | 1.57B | 5.63B | |
Tangible asset value | 11.98B | 12.03B | 14.08B | 14.89B | 17.69B | |
Net current asset value | 1.03B | 1.78B | 3.69B | 895.58M | 4.9B | |
Invested capital | 0.06 | 0.12 | 0.06 | 0.14 | 0.04 | |
Average receivables | 3.39B | 4.97B | 4.18B | 3.09B | 3.82B | |
Average payables | 2.67B | 3.08B | 3.38B | 3.8B | 4.13B | |
Average inventory | 2.08B | 2.33B | 2.73B | 3.29B | 3.43B | |
Days sales outstanding | 58.58 | 77.14 | 34.71 | 39.73 | 45.15 | |
Days payables outstanding | 113.26 | 132.62 | 135.29 | 135.74 | 126.48 | |
Days of inventory on hand | 86.2 | 100 | 115.91 | 118.76 | 99.67 | |
Receivables turnover | 6.23 | 4.73 | 10.52 | 9.19 | 8.08 | |
Payables turnover | 3.22 | 2.75 | 2.7 | 2.69 | 2.89 | |
Inventory turnover | 4.23 | 3.65 | 3.15 | 3.07 | 3.66 | |
ROE | 0.15 | 0.17 | 0.26 | 0.4 | 0.28 | |
Capex per share | -3.07 | -3.5 | -0.76 | -10.88 | -0.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.25 | 18.98 | 18.77 | 19.82 | 22.83 | |
Net income per share | 5.37 | 3.28 | 3.13 | 4.09 | 5.92 | |
Operating cash flow per share | 2.14 | 2.9 | 2.09 | 2.11 | 2.1 | |
Free cash flow per share | 2.14 | 2.9 | 2.09 | 2.11 | 2.1 | |
Cash per share | 5.65 | 8.39 | 6.8 | 11.35 | 0 | |
Book value per share | 53.07 | 52.28 | 52.56 | 55.12 | 0 | |
Tangible book value per share | 0 | 40.16 | 0 | 43.96 | 0 | |
Share holders equity per share | 53.07 | 52.28 | 52.56 | 55.12 | 0 | |
Interest debt per share | 0.04 | 2.09 | 0.05 | 2.51 | 0.06 | |
Market cap | 187.69B | 157.92B | 186.87B | 235B | 249.99B | |
Enterprise value | 190.19B | 158.35B | 189.86B | 235.23B | 249.99B | |
P/E ratio | 19.79 | 27.33 | 33.92 | 32.91 | 24.18 | |
Price to sales ratio | 19.1 | 18.89 | 22.63 | 27.17 | 25.09 | |
POCF ratio | 198.66 | 123.43 | 203.12 | 254.93 | 272.85 | |
PFCF ratio | 198.66 | 123.43 | 203.12 | 254.93 | 272.85 | |
P/B Ratio | 8.01 | 6.86 | 8.08 | 9.77 | 0 | |
PTB ratio | 8.01 | 6.86 | 8.08 | 9.77 | 0 | |
EV to sales | 19.35 | 18.94 | 23 | 27.2 | 25.09 | |
Enterprise value over EBITDA | 63.29 | 74.27 | 95.99 | 96.34 | 75.63 | |
EV to operating cash flow | 201.3 | 123.77 | 206.37 | 255.18 | 272.85 | |
EV to free cash flow | 201.3 | 123.77 | 206.37 | 255.18 | 272.85 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.04 | 0 | 0.04 | 0 | |
Debt to assets | 0 | 0.03 | 0 | 0.03 | 0 | |
Net debt to EBITDA | 0.83 | 0.21 | 1.51 | 0.09 | 0 | |
Current ratio | 0 | 1.78 | 0 | 1.82 | 0 | |
Interest coverage | 143.08 | 108.93 | 67.29 | 88.03 | 105.07 | |
Income quality | 0.4 | 0.89 | 0.67 | 0.52 | 0.35 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.03 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.17 | 0 | 0.15 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 80.07 | 62.11 | 60.84 | 71.22 | 0 | |
ROIC | 0.1 | 0.06 | 0.06 | 0.07 | 0 | |
Return on tangible assets | 0 | 0.06 | 0 | 0.06 | 0 | |
Graham Net | 5.65 | 1.19 | 6.8 | 3.17 | 0 | |
Working capital | 2.5B | 5.63B | 2.99B | 6.73B | 0 | |
Tangible asset value | 0 | 17.69B | 0 | 19.18B | 0 | |
Net current asset value | 2.5B | 4.9B | 2.99B | 5.94B | 0 | |
Invested capital | 0 | 0.04 | 0 | 0.04 | 0 | |
Average receivables | 1.79B | 2.11B | 2.11B | 2.44B | 2.44B | |
Average payables | 2.1B | 2.08B | 2.08B | 2.39B | 2.39B | |
Average inventory | 1.89B | 1.64B | 1.64B | 1.8B | 1.8B | |
Days sales outstanding | 0 | 45.36 | 0 | 50.7 | 0 | |
Days payables outstanding | 0 | 121.58 | 0 | 165.97 | 0 | |
Days of inventory on hand | 0 | 95.8 | 0 | 125.42 | 0 | |
Receivables turnover | 0 | 1.98 | 0 | 1.78 | 0 | |
Payables turnover | 0 | 0.74 | 0 | 0.54 | 0 | |
Inventory turnover | 0 | 0.94 | 0 | 0.72 | 0 | |
ROE | 0.1 | 0.06 | 0.06 | 0.07 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
EMAMILTD.NS Frequently Asked Questions
What is Emami Limited stock symbol ?
Emami Limited is a IN stock and trading under the symbol EMAMILTD.NS
What is Emami Limited stock quote today ?
Emami Limited stock price is $439.25 today.
Is Emami Limited stock public?
Yes, Emami Limited is a publicly traded company.